Jing Liang

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Don M. Benson, Courtney E. Bakan, Shuhong Zhang et al. · Blood · 2011 · 199 citations · Full text

Expression of VLDLR in the Retina and Evolution of Subretinal Neovascularization in the Knockout Mouse Model’s Retinal Angiomatous Proliferation

Wenzheng Hu, Aihua Jiang, Jing Liang et al. · Investigative Ophthalmology & Visual Science · 2008 · 125 citations

Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD‐2076, against multiple myeloma

Xiaojing Wang, Anthony L. Sinn, Karen E. Pollok et al. · British Journal of Haematology · 2010 · 49 citations

Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis

Zhijie Chen, Mengyuan Lv, Jing Liang et al. · Advanced Science · 2023 · 42 citations · Full text